Moreover, on a functional level, it could be demonstrated, in the in vivo MC38 colon cancer model, that the therapeutic blockade of TGFβ resulted in the increased tumor infiltration of CD8+ T cells and NK cells [138]. The gene discussed is CD8A; the disease is colonic neoplasm.